Compare Sana Biotechnology Inc (SANA) vs Valaris Limited Common Shares (VAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Valaris Limited Common Shares — how do they compare? Sana Biotechnology Inc trades at $2.33 (market cap $719.96M), while Valaris Limited Common Shares trades at $84.6 (market cap $5.94B). The key difference: Valaris Limited Common Shares is far larger — about 8.3× Sana Biotechnology Inc's market cap, and Valaris Limited Common Shares is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 24 Days and Valaris Limited Common Shares for 0 Days on average.
| SANA | VAL | |
|---|---|---|
Market Cap | $719.96M | $5.94B |
Volume | 4,901,517 | 742,554 |
Sector | Health | Energy |
52-Week High | $5.92 | $113.42 |
52-Week Low | $2.33 | $48.15 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $633.21M | $6.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.41, down 8.02% today, with a bearish technical signal despite bullish oscillators showing oversold conditions. The company shows no revenue with substantial losses (-$244.17M net income in 2025) and negative cash flow, though analyst consensus remains strongly positive with 82% buy ratings. Recent investor conference presentations indicate active business development efforts.
The stock presents high-risk speculative potential with strong Wall Street support but faces fundamental challenges including no revenue generation and significant cash burn. Investment opportunity hinges on successful clinical developments, while risks include continued operational losses and potential dilution from financing activities.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Valaris Limited Common Shares
Valaris Limited provides offshore contract drilling services to the oil and gas industry, operating a fleet of drillships, semisubmersibles, and jackup rigs across multiple regions worldwide.
Read more on VAL →
